| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | AMNEAL PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $190,000 | |
| 2026 | AMNEAL PHARMACEUTICALS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $190,000 | |
| 2025 | AMNEAL PHARMACEUTICALS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $340,000 | |
| 2025 | AMNEAL PHARMACEUTICALS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $310,000 | |
| 2025 | AMNEAL PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $210,000 | |
| 2025 | AMNEAL PHARMACEUTICALS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $910,000 | |
| 2024 | AMNEAL PHARMACEUTICALS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $210,000 | |
| 2024 | AMNEAL PHARMACEUTICALS |
3rd Quarter (July 1 - Sep 30) AMENDED |
— | $230,000 | |
| 2024 | AMNEAL PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) AMENDED |
— | $240,000 | |
| 2024 | AMNEAL PHARMACEUTICALS |
1st Quarter (Jan 1 - Mar 31) AMENDED |
— | $850,000 |
| Client | Filings | Total Income |
|---|---|---|
| AMNEAL PHARMACEUTICALS | 16 | — |
| Name | Disclosed Prior Position |
|---|---|
| JULIAN MALASI |